CoChat

Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps

Open access
Baczek, Jan, Silkiewicz, Marta, Wojszel, Zyta Beata · 2020 · Nutrients
Cited by 156

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Sarcopenia is a geriatric syndrome with a significant impact on older patients’ quality of life, morbidity and mortality. Despite the new available criteria, its early diagnosis remains difficult, highlighting the necessity of looking for a valid muscle wasting biomarker. Myostatin, a muscle mass negative regulator, is one of the potential candidates. The aim of this work is to point out various factors affecting the potential of myostatin as a biomarker of muscle wasting. Based on the literature review, we can say that recent studies produced conflicting results and revealed a number of potential confounding factors influencing their use in sarcopenia diagnosing. These factors include physiological variables (such as age, sex and physical activity) as well as a variety of disorders (including heart failure, metabolic syndrome, kidney failure and inflammatory diseases) and differences in laboratory measurement methodology. Our conclusion is that although myostatin alone might not prove to be a feasible biomarker, it could become an important part of a recently proposed panel of muscle wasting biomarkers. However, a thorough understanding of the interrelationship of these markers, as well as establishing a valid measurement methodology for myostatin and revising current research data in the light of new criteria of sarcopenia, is needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu12082401

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 155

  1. Uemura, 2019, Sarcopenia and Low Serum Albumin Level Synergistically Increase the Risk of Incident Disability in Older Adults, J. Am. Med. Dir. Assoc., 20, 90, 10.1016/j.jamda.2018.06.011 · DOI
  2. Beaudart, 2015, Quality of life and physical components linked to sarcopenia: The SarcoPhAge study, Exp. Gerontol., 69, 103, 10.1016/j.exger.2015.05.003 · DOI · Paper page
  3. Arroyo, 2013, Mortality as an adverse outcome of sarcopenia, J. Nutr. Health Aging, 17, 259, 10.1007/s12603-012-0434-0 · DOI · Paper page
  4. Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.Y., and Bruyere, O. (2017). Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS ONE, 12. · DOI · Paper page
  5. Welle, 2003, Gene expression profile of aging in human muscle, Physiol. Genom., 14, 149, 10.1152/physiolgenomics.00049.2003 · DOI · Paper page
  6. Schrager, 2004, Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span, J. Appl. Physiol. (1985), 97, 2176, 10.1152/japplphysiol.00985.2003 · DOI · Paper page
  7. Rong, Y.D., Bian, A.L., Hu, H.Y., Ma, Y., and Zhou, X.Z. (2018). Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr., 18. · DOI · Paper page
  8. Visser, 2003, Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam, J. Clin. Endocrinol. Metab., 88, 5766, 10.1210/jc.2003-030604 · DOI · Paper page
  9. Bian, A., Ma, Y., Zhou, X., Guo, Y., Wang, W., Zhang, Y., and Wang, X. (2020). Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet. Disord., 21. · DOI · Paper page
  10. Hiona, A., Sanz, A., Kujoth, G.C., Pamplona, R., Seo, A.Y., Hofer, T., Someya, S., Miyakawa, T., Nakayama, C., and Samhan-Arias, A.K. (2010). Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS ONE, 5. · DOI · Paper page
  11. Kuh, 2005, Grip strength, postural control, and functional leg power in a representative cohort of British men and women: Associations with physical activity, health status, and socioeconomic conditions, J. Gerontol. A Biol. Sci. Med. Sci., 60, 224, 10.1093/gerona/60.2.224 · DOI · Paper page
  12. Kortebein, 2008, Functional impact of 10 days of bed rest in healthy older adults, J. Gerontol. A Biol. Sci. Med. Sci., 63, 1076, 10.1093/gerona/63.10.1076 · DOI · Paper page
  13. Hai, 2017, Association between sarcopenia and nutritional status and physical activity among community-dwelling Chinese adults aged 60 years and older, Geriatr. Gerontol. Int., 17, 1959, 10.1111/ggi.13001 · DOI
  14. Bahat, 2010, Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey, Aging Male, 13, 211, 10.3109/13685538.2010.489130 · DOI · Paper page
  15. McDermott, 2001, Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599 · DOI · Paper page
  16. Morley, 2018, Treatment of sarcopenia: The road to the future, J. Cachexia Sarcopenia Muscle, 9, 1196, 10.1002/jcsm.12386 · DOI · Paper page
  17. Yaxley, 2012, The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a combination of these conditions?, Asia Pac. J. Clin. Nutr., 21, 386
  18. Gingrich, A., Volkert, D., Kiesswetter, E., Thomanek, M., Bach, S., Sieber, C.C., and Zopf, Y. (2019). Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatr., 19. · DOI · Paper page
  19. Narumi, 2015, Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure, Eur. J. Intern. Med., 26, 118, 10.1016/j.ejim.2015.01.008 · DOI
  20. Hu, 2018, Sarcopenia and long-term prognosis of patients with chronic heart failure in patients aged 70 years and over, Zhonghua Nei Ke Za Zhi, 57, 212
  21. Pereira, 2015, Sarcopenia in chronic kidney disease on conservative therapy: Prevalence and association with mortality, Nephrol. Dial. Transplant., 30, 1718, 10.1093/ndt/gfv133 · DOI · Paper page
  22. Mauro, 2020, Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List, Transplantation, 104, e188, 10.1097/TP.0000000000003222 · DOI
  23. Scherbakov, 2018, Cachexia as a common characteristic in multiple chronic disease, J. Cachexia Sarcopenia Muscle, 9, 1189, 10.1002/jcsm.12388 · DOI
  24. Bowen, 2015, Skeletal muscle wasting in cachexia and sarcopenia: Molecular pathophysiology and impact of exercise training, J. Cachexia Sarcopenia Muscle, 6, 197, 10.1002/jcsm.12043 · DOI · Paper page
  25. Argiles, 2006, Muscle wasting in cancer and ageing: Cachexia versus sarcopenia, Adv. Gerontol., 18, 39
  26. Douglas, 2014, Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score, Cancer Treat. Rev., 40, 685, 10.1016/j.ctrv.2013.11.007 · DOI
  27. Silva, 2020, Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care, Clin. Nutr., 39, 1587, 10.1016/j.clnu.2019.07.002 · doi:10.1016/j.clnu.2019.07.002
  28. Califf, 2018, Biomarker definitions and their applications, Exp. Biol. Med. (Maywood), 243, 213, 10.1177/1535370217750088 · DOI · Paper page
  29. Calvani, 2015, Biomarkers for physical frailty and sarcopenia: State of the science and future developments, J. Cachexia Sarcopenia Muscle, 6, 278, 10.1002/jcsm.12051 · DOI · Paper page
  30. Sharma, 1999, Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct, J. Cell Physiol., 180, 1, 10.1002/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V · DOI · Paper page
  31. Thies, 2001, GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding, Growth Factors, 18, 251, 10.3109/08977190109029114 · DOI · Paper page
  32. Wolfman, 2003, Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases, Proc. Natl. Acad. Sci. USA, 100, 15842, 10.1073/pnas.2534946100 · DOI · Paper page
  33. Langley, 2002, Myostatin inhibits myoblast differentiation by down-regulating MyoD expression, J. Biol. Chem., 277, 49831, 10.1074/jbc.M204291200 · DOI · Paper page
  34. Rebbapragada, 2003, Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis, Mol. Cell Biol., 23, 7230, 10.1128/MCB.23.20.7230-7242.2003 · DOI · Paper page
  35. Hennebry, 2009, Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression, Am. J. Physiol. Cell Physiol., 296, C525, 10.1152/ajpcell.00259.2007 · DOI · Paper page
  36. Amirouche, 2009, Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle, Endocrinology, 150, 286, 10.1210/en.2008-0959 · DOI · Paper page
  37. Bonala, 2014, Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake, J. Biol. Chem., 289, 7654, 10.1074/jbc.M113.529925 · DOI
  38. Bonala, 2013, Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity, Mol. Endocrinol., 27, 1518, 10.1210/me.2013-1048 · DOI
  39. Ma, 2001, Characterization of 5’-regulatory region of human myostatin gene: Regulation by dexamethasone in vitro, Am. J. Physiol. Endocrinol. Metab., 281, E1128, 10.1152/ajpendo.2001.281.6.E1128 · DOI · Paper page
  40. Valdes, 2013, IGF-1 induces IP3 -dependent calcium signal involved in the regulation of myostatin gene expression mediated by NFAT during myoblast differentiation, J. Cell Physiol., 228, 1452, 10.1002/jcp.24298 · DOI
  41. Lenk, 2009, Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model, Eur. J. Heart Fail., 11, 342, 10.1093/eurjhf/hfp020 · DOI · Paper page
  42. Wang, 2008, Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway, J. Endocrinol., 197, 85, 10.1677/JOE-07-0596 · DOI
  43. Carneiro, 2008, Hypothyroidism is associated with increased myostatin expression in rats, J. Endocrinol. Investig., 31, 773, 10.1007/BF03349256 · DOI
  44. Qiu, 2013, Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanism, Proc. Natl. Acad. Sci. USA, 110, 18162, 10.1073/pnas.1317049110 · DOI · Paper page
  45. Drummond, 2009, Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle, J. Nutr., 139, 2279, 10.3945/jn.109.112797 · DOI
  46. Kim, 2007, Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: A cluster analysis, J. Appl. Physiol. (1985), 103, 1488, 10.1152/japplphysiol.01194.2006 · DOI
  47. Li, 2019, Effect of Hypoxia on the Muscle Fiber Switching Signal Pathways CnA/NFATc1 and Myostatin in Mouse Myocytes, Acta Histochem., 121, 539, 10.1016/j.acthis.2019.04.001 · DOI
  48. Forbes, 2006, Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism, J. Cell. Physiol., 206, 264, 10.1002/jcp.20477 · DOI · Paper page
  49. Callis, 2009, MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice, J. Clin. Investig., 119, 2772, 10.1172/JCI36154 · DOI · Paper page
  50. Liu, 2007, An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133, Proc. Natl. Acad. Sci. USA, 104, 20844, 10.1073/pnas.0710558105 · DOI · Paper page
  51. Welle, 2002, Insulin-like growth factor-1 and myostatin mRNA expression in muscle: Comparison between 62–77 and 21–31 yr old men, Exp. Gerontol., 37, 833, 10.1016/S0531-5565(02)00025-6 · DOI
  52. Elliott, 2012, The central role of myostatin in skeletal muscle and whole body homeostasis, Acta Physiol. (Oxf.), 205, 324, 10.1111/j.1748-1716.2012.02423.x · DOI · Paper page
  53. Huang, 2011, Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation, Cell. Signal., 23, 1441, 10.1016/j.cellsig.2011.05.003 · DOI
  54. Dschietzig, 2014, Myostatin—From the Mighty Mouse to cardiovascular disease and cachexia, Clin. Chim. Acta, 433, 216, 10.1016/j.cca.2014.03.021 · DOI
  55. Yamada, 2016, Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use, Calcif. Tissue Int., 99, 13, 10.1007/s00223-016-0118-6 · DOI
  56. Zhou, Y., Hellberg, M., Hellmark, T., Hoglund, P., and Clyne, N. (2019). Muscle mass and plasma myostatin after exercise training: A substudy of Renal Exercise (RENEXC)—A randomized controlled trial. Nephrol. Dial. Transplant. · DOI
  57. Loumaye, 2015, Role of Activin A and myostatin in human cancer cachexia, J. Clin. Endocrinol. Metab., 100, 2030, 10.1210/jc.2014-4318 · DOI · Paper page
  58. Comas, 2019, Circulating Irisin and Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects, Front. Physiol., 10, 871, 10.3389/fphys.2019.00871 · DOI · Paper page
  59. Furihata, 2016, Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure, Int. J. Cardiol., 220, 483, 10.1016/j.ijcard.2016.06.231 · DOI
  60. Delanaye, 2019, Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis, J. Ren. Nutr., 29, 511, 10.1053/j.jrn.2018.11.010 · DOI
  61. Moriwaki, K., Matsumoto, H., Tanishima, S., Tanimura, C., Osaki, M., Nagashima, H., and Hagino, H. (2019). Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: A cross-sectional study. BMC Musculoskelet. Disord., 20. · DOI
  62. Hofmann, 2015, Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women, Exp. Gerontol., 64, 35, 10.1016/j.exger.2015.02.008 · DOI
  63. Negaresh, 2019, Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-body Resistance Training, Int. J. Prev. Med., 10, 29, 10.4103/ijpvm.IJPVM_310_17 · DOI
  64. Koyun, 2018, Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients, Saudi J. Kidney Dis. Transpl., 29, 809, 10.4103/1319-2442.239648 · DOI
  65. Carvalho, 2018, Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults, Cytokine, 107, 118, 10.1016/j.cyto.2017.12.008 · DOI
  66. Arrieta, 2019, Serum Myostatin Levels Are Higher in Fitter, More Active, and Non-Frail Long-Term Nursing Home Residents and Increase after a Physical Exercise Intervention, Gerontology, 65, 229, 10.1159/000494137 · DOI · Paper page
  67. Parnell, 2018, Activin subfamily peptides predict chronological age in humans, Physiol. Rep., 6, e13823, 10.14814/phy2.13823 · DOI
  68. Han, 2016, Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia, Sci. Rep., 6, 19457, 10.1038/srep19457 · DOI · Paper page
  69. Tay, 2015, Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults, Age (Dordr), 37, 121, 10.1007/s11357-015-9860-3 · DOI · Paper page
  70. Roh, 2019, Altered gene and protein expressions of vitamin D receptor in skeletal muscle in sarcopenic patients who sustained distal radius fractures, J. Bone Miner Metab., 37, 920, 10.1007/s00774-019-00995-0 · DOI
  71. Hedayati, 2016, Can the Serum Level of Myostatin be Considered as an Informative Factor for Cachexia Prevention in Patients with Medullary Thyroid Cancer?, Asian Pac. J. Cancer Prev., 17, 119, 10.7314/APJCP.2016.17.S3.119 · DOI
  72. Kim, 2019, Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors, J. Geriatr. Oncol., 10, 749, 10.1016/j.jgo.2019.03.015 · DOI
  73. Burch, 2017, Reduced serum myostatin concentrations associated with genetic muscle disease progression, J. Neurol., 264, 541, 10.1007/s00415-016-8379-6 · DOI
  74. Mariot, 2017, Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches, Nat. Commun., 8, 1859, 10.1038/s41467-017-01486-4 · DOI · Paper page
  75. Koch, 2020, Myostatin: A Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients, Mol. Ther. Methods Clin. Dev., 17, 1178, 10.1016/j.omtm.2020.04.022 · DOI
  76. Mariot, 2020, Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy, Mol. Ther. Methods Clin. Dev., 18, 415, 10.1016/j.omtm.2020.06.016 · DOI
  77. Vernerova, L., Horvathova, V., Kropackova, T., Vokurkova, M., Klein, M., Tomcik, M., Oreska, S., Spiritovic, M., Storkanova, H., and Hermankova, B. (2020). Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies. Rheumatology (Oxford). · DOI
  78. Lakshman, 2009, Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration, Mol. Cell Endocrinol., 302, 26, 10.1016/j.mce.2008.12.019 · DOI
  79. Wintgens, 2012, Plasma myostatin measured by a competitive ELISA using a highly specific antiserum, Clin. Chim. Acta, 413, 1288, 10.1016/j.cca.2012.04.023 · DOI
  80. Breitbart, A., Scharf, G.M., Duncker, D., Widera, C., Gottlieb, J., Vogel, A., Schmidt, S., Brandes, G., Heuft, H.G., and Lichtinghagen, R. (2013). Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients. PLoS ONE, 8. · DOI
  81. Cote, 2020, A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation, SLAS Discov., 25, 95, 10.1177/2472555219860779 · DOI
  82. Zhang, 2019, A sensitive antibody-free 2D-LC-MS/MS assay for the quantitation of myostatin in the serum of different species, Bioanalysis, 11, 957, 10.4155/bio-2018-0311 · DOI
  83. Zhu, 2011, Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis, Am. J. Pathol., 179, 915, 10.1016/j.ajpath.2011.04.008 · DOI
  84. Saitoh, 2020, Discovery of a follistatin-derived myostatin inhibitory peptide, Bioorg. Med. Chem. Lett., 30, 126892, 10.1016/j.bmcl.2019.126892 · DOI
  85. Schafer, 2016, Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease, Cell Metab., 23, 1207, 10.1016/j.cmet.2016.05.023 · DOI · Paper page
  86. Chew, 2019, Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults, J. Nutr. Health Aging, 23, 979, 10.1007/s12603-019-1255-1 · DOI · Paper page
  87. Fife, E., Kostka, J., Kroc, L., Guligowska, A., Piglowska, M., Soltysik, B., Kaufman-Szymczyk, A., Fabianowska-Majewska, K., and Kostka, T. (2018). Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men. BMC Geriatr., 18. · DOI · Paper page
  88. Kalampouka, 2018, Differing Effects of Younger and Older Human Plasma on C2C12 Myocytes in Vitro, Front. Physiol., 9, 152, 10.3389/fphys.2018.00152 · DOI
  89. Yarasheski, 2002, Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting, J. Nutr. Health Aging, 6, 343
  90. Agergaard, 2015, Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men?—A randomized controlled trial, Nutr. Metab. (Lond.), 12, 32, 10.1186/s12986-015-0029-y · DOI · Paper page
  91. Covington, 2016, Myokine Expression in Muscle and Myotubes in Response to Exercise Stimulation, Med. Sci. Sports Exerc., 48, 384, 10.1249/MSS.0000000000000787 · DOI · Paper page
  92. Hansson, 2019, Skeletal muscle signaling responses to resistance exercise of the elbow extensors are not compromised by a preceding bout of aerobic exercise, Am. J. Physiol. Regul. Integr. Comp. Physiol., 317, R83, 10.1152/ajpregu.00022.2019 · DOI
  93. Hinkley, 2017, Short-term intense exercise training reduces stress markers and alters the transcriptional response to exercise in skeletal muscle, Am. J. Physiol. Regul. Integr. Comp. Physiol., 312, R426, 10.1152/ajpregu.00356.2016 · DOI
  94. Ross, 2019, Skeletal Muscle mRNA Response to Hypobaric and Normobaric Hypoxia After Normoxic Endurance Exercise, High Alt. Med. Biol., 20, 141, 10.1089/ham.2018.0147 · DOI
  95. Schwarz, 2016, Effect of resistance exercise intensity on the expression of PGC-1alpha isoforms and the anabolic and catabolic signaling mediators, IGF-1 and myostatin, in human skeletal muscle, Appl. Physiol. Nutr. Metab., 41, 856, 10.1139/apnm-2016-0047 · DOI
  96. Silvennoinen, 2015, PGC-1 isoforms and their target genes are expressed differently in human skeletal muscle following resistance and endurance exercise, Physiol. Rep., 3, e12563, 10.14814/phy2.12563 · DOI · Paper page
  97. Watson, 2017, The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease, Front. Physiol., 8, 541, 10.3389/fphys.2017.00541 · DOI
  98. Shad, 2019, One Week of Step Reduction Lowers Myofibrillar Protein Synthesis Rates in Young Men, Med. Sci. Sports Exerc., 51, 2125, 10.1249/MSS.0000000000002034 · DOI
  99. Han, D.S., Hsiao, M.Y., Wang, T.G., Chen, S.Y., and Yang, W.S. (2016). Association of serum myokines and aerobic exercise training in patients with spinal cord injury: An observational study. BMC Neurol., 16. · DOI
  100. He, 2018, Myokine Response to High-Intensity Interval vs. Resistance Exercise: An Individual Approach, Front. Physiol., 9, 1735, 10.3389/fphys.2018.01735 · DOI
  101. Kabak, B., Belviranli, M., and Okudan, N. (2018). Irisin and myostatin responses to acute high-intensity interval exercise in humans. Horm. Mol. Biol. Clin. Investig., 35. · DOI
  102. Kerschan-Schindl, K., Thalmann, M.M., Weiss, E., Tsironi, M., Foger-Samwald, U., Meinhart, J., Skenderi, K., and Pietschmann, P. (2015). Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race. PLoS ONE, 10. · DOI · Paper page
  103. Paoli, 2015, Protein supplementation increases postexercise plasma myostatin concentration after 8 weeks of resistance training in young physically active subjects, J. Med. Food, 18, 137, 10.1089/jmf.2014.0004 · DOI
  104. Farhani, 2019, Blood Flow Restriction During Futsal Training Increases Muscle Activation and Strength, Front. Physiol., 10, 614, 10.3389/fphys.2019.00614 · DOI
  105. Bagheri, 2019, Effects of upper-body, lower-body, or combined resistance training on the ratio of follistatin and myostatin in middle-aged men, Eur. J. Appl. Physiol., 119, 1921, 10.1007/s00421-019-04180-z · DOI
  106. Mafi, 2019, Improvement in Skeletal Muscle Strength and Plasma Levels of Follistatin and Myostatin Induced by an 8-Week Resistance Training and Epicatechin Supplementation in Sarcopenic Older Adults, J. Aging Phys. Act., 27, 384, 10.1123/japa.2017-0389 · DOI · Paper page
  107. Micielska, 2019, The beneficial effects of 15 units of high-intensity circuit training in women is modified by age, baseline insulin resistance and physical capacity, Diabetes Res. Clin. Pract., 152, 156, 10.1016/j.diabres.2019.05.009 · DOI · Paper page
  108. Wu, 2019, Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa, Clin. Endocrinol. (Oxf.), 90, 88, 10.1111/cen.13871 · DOI
  109. Tsioga, 2015, Plasma myostatin is only a weak predictor for weight maintenance in obese adults, Exp. Clin. Endocrinol. Diabetes, 123, 466, 10.1055/s-0035-1559663 · DOI
  110. Assyov, 2017, Myostatin and carbohydrate disturbances, Endocr. Res., 42, 102, 10.1080/07435800.2016.1198802 · DOI
  111. Tanaka, 2018, Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients, Diabetes Res. Clin. Pract., 142, 195, 10.1016/j.diabres.2018.05.041 · DOI
  112. 2016, Relationship between myostatin and irisin in type 2 diabetes mellitus: A compensatory mechanism to an unfavourable metabolic state?, Endocrine, 52, 54, 10.1007/s12020-015-0758-8 · DOI
  113. Zhao, 2018, Early second trimester maternal serum markers in the prediction of gestational diabetes mellitus, J. Diabetes Investig., 9, 967, 10.1111/jdi.12798 · DOI
  114. Li, 2016, Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis, Endocrinology, 157, 282, 10.1210/en.2015-1546 · DOI
  115. Kong, 2018, Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin, Cell Metab., 28, 631, 10.1016/j.cmet.2018.07.004 · DOI · Paper page
  116. Steculorum, 2016, AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue, Cell, 165, 125, 10.1016/j.cell.2016.02.044 · DOI · Paper page
  117. Consitt, 2018, The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials, J. Frailty Aging, 7, 21
  118. Akerfeldt, 2015, Postsurgical Acute Phase Reaction is Associated with Decreased Levels of Circulating Myostatin, Inflammation, 38, 1727, 10.1007/s10753-015-0149-6 · DOI
  119. Wallner, 2019, Myostatin serum concentration as an indicator for deviated muscle metabolism in severe burn injuries, Scand. J. Surg., 108, 297, 10.1177/1457496918812230 · DOI
  120. Zhao, C., Shao, Y., Lin, C., Zeng, C., Fang, H., Pan, J., and Cai, D. (2017). Myostatin serum concentrations are correlated with the severity of knee osteoarthritis. J. Clin. Lab. Anal., 31. · DOI
  121. Su, 2019, Myostatin induces tumor necrosis factor-alpha expression in rheumatoid arthritis synovial fibroblasts through the PI3K-Akt signaling pathway, J. Cell. Physiol., 234, 9793, 10.1002/jcp.27665 · DOI
  122. Ebenbichler, 2019, Rheumatoid arthritis in remission: Decreased myostatin and increased serum levels of periostin, Wien. Klin. Wochenschr., 131, 1, 10.1007/s00508-018-1386-0 · DOI
  123. Anker, 1997, Wasting as independent risk factor for mortality in chronic heart failure, Lancet, 349, 1050, 10.1016/S0140-6736(96)07015-8 · DOI · Paper page
  124. Gruson, 2011, Increased plasma myostatin in heart failure, Eur. J. Heart Fail., 13, 734, 10.1093/eurjhf/hfr024 · DOI
  125. Ishida, 2017, Myostatin signaling is up-regulated in female patients with advanced heart failure, Int. J. Cardiol., 238, 37, 10.1016/j.ijcard.2017.03.153 · DOI
  126. Chen, 2019, Predictive value of serum myostatin for the severity and clinical outcome of heart failure, Eur. J. Intern. Med., 64, 33, 10.1016/j.ejim.2019.04.017 · DOI
  127. Meloux, A., Rochette, L., Maza, M., Bichat, F., Tribouillard, L., Cottin, Y., Zeller, M., and Vergely, C. (2019). Growth Differentiation Factor-8 (GDF8)/Myostatin is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction. J. Clin. Med., 9. · DOI
  128. Han, 2017, Relation between serum myokines and phase II cardiac rehabilitation, Medicine (Baltimore), 96, e6579, 10.1097/MD.0000000000006579 · DOI
  129. Baan, 2015, Myostatin and IGF-I signaling in end-stage human heart failure: A qRT-PCR study, J. Transl. Med., 13, 1, 10.1186/s12967-014-0365-0 · DOI
  130. Castillero, 2018, Structural and functional cardiac profile after prolonged duration of mechanical unloading: Potential implications for myocardial recovery, Am. J. Physiol. Heart Circ. Physiol., 315, H1463, 10.1152/ajpheart.00187.2018 · DOI
  131. Antunez, 2015, Myostatin and insulin-like growth factor-1 in hypertensive heart disease: A prospective study in human heart donors, J. Hypertens., 33, 851, 10.1097/HJH.0000000000000493 · DOI
  132. Fernlund, 2017, Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young, Pediatr. Cardiol., 38, 853, 10.1007/s00246-017-1593-x · DOI
  133. Ju, C.R., Chen, M., Zhang, J.H., Lin, Z.Y., and Chen, R.C. (2016). Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease. PLoS ONE, 11. · DOI
  134. Ju, 2017, Plasma myostatin levels are related to the extent of right ventricular dysfunction in exacerbation of chronic obstructive pulmonary disease, Biomarkers, 22, 246, 10.1080/1354750X.2016.1203999 · DOI
  135. Zhang, 2018, Correlation between peripheral skeletal muscle functions and the stable phase of COPD in older patients, Eur. Rev. Med. Pharmacol. Sci., 22, 5317
  136. Qi, 2019, MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARgamma/NF-kappaB, Mol. Ther. Nucleic Acids, 19, 507, 10.1016/j.omtn.2019.12.003 · DOI
  137. Biesemann, 2015, Myostatin induces interstitial fibrosis in the heart via TAK1 and p38, Cell Tissue Res., 361, 779, 10.1007/s00441-015-2139-2 · DOI
  138. Yano, S., Nagai, A., Isomura, M., Yamasaki, M., Kijima, T., Takeda, M., Hamano, T., and Nabika, T. (2015). Relationship between Blood Myostatin Levels and Kidney Function:Shimane CoHRE Study. PLoS ONE, 10. · DOI
  139. Raptis, 2018, Serum Fas Ligand, Serum Myostatin and Urine TGF-beta1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function, Kidney Blood Press. Res., 43, 744, 10.1159/000489911 · doi:10.1159/000489911
  140. Esposito, 2017, Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities, BioMed Res. Int., 2017, 7635459, 10.1155/2017/7635459 · DOI
  141. Esposito, P., Battaglia, Y., La Porta, E., Grignano, M.A., Caramella, E., Avella, A., Peressini, S., Sessa, N., Albertini, R., and Di Natali, G. (2019). Significance of serum Myostatin in hemodialysis patients. BMC Nephrol., 20. · DOI
  142. Wang, 2015, Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease, Oxid. Med. Cell. Longev., 2015, 684965, 10.1155/2015/684965 · DOI
  143. Carrarelli, 2015, Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis, Fertil. Steril., 104, 744, 10.1016/j.fertnstert.2015.05.032 · DOI
  144. Carrarelli, 2017, Deep Infiltrating Endometriosis and Endometrial Adenocarcinoma Express High Levels of Myostatin and Its Receptors Messenger RNAs, Reprod. Sci., 24, 1577, 10.1177/1933719117698579 · DOI
  145. Peiris, 2015, Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment, Reprod. Sci., 22, 1202, 10.1177/1933719115572482 · DOI
  146. Tsigkou, 2015, Expression Levels of Myostatin and Matrix Metalloproteinase 14 mRNAs in Uterine Leiomyoma are Correlated With Dysmenorrhea, Reprod. Sci., 22, 1597, 10.1177/1933719115592710 · DOI
  147. Trappe, 2013, Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults, Am. J. Physiol. Regul. Integr. Comp. Physiol., 304, R198, 10.1152/ajpregu.00245.2012 · DOI · Paper page
  148. Patel, 2018, Prior acetaminophen consumption impacts the early adaptive cellular response of human skeletal muscle to resistance exercise, J. Appl. Physiol. (1985), 124, 1012, 10.1152/japplphysiol.00922.2017 · DOI
  149. Heisterberg, 2018, Effect of Losartan on the Acute Response of Human Elderly Skeletal Muscle to Exercise, Med. Sci. Sports Exerc., 50, 225, 10.1249/MSS.0000000000001438 · DOI
  150. Schakman, 2009, Mechanisms of muscle atrophy induced by glucocorticoids, Horm. Res., 72, 36
  151. Wang, R., Jiao, H., Zhao, J., Wang, X., and Lin, H. (2016). Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage. PLoS ONE, 11. · DOI
  152. Macedo, 2016, Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone, Steroids, 107, 30, 10.1016/j.steroids.2015.12.016 · DOI
  153. Dhindsa, 2019, Acute effects of insulin on skeletal muscle growth and differentiation genes in men with type 2 diabetes, Eur. J. Endocrinol., 181, K55, 10.1530/EJE-19-0514 · DOI
  154. Hong, 2019, Long-term insulin treatment leads to a change in myosin heavy chain fiber distribution in OLETF rat skeletal muscle, J. Cell. Biochem., 120, 2404, 10.1002/jcb.27571 · DOI
  155. Yamakage, 2020, Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial, J. Diabetes Investig., 11, 653, 10.1111/jdi.13179 · DOI

Cited by

See all 156

Metadata

Authors
Baczek, J., Silkiewicz, M., & Wojszel, Z. B.
Venue
Nutrients
Publisher
MDPI AG
Published
2020-08-11
Volume
12
Issue
8
Pages
2401
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3048382626
Cited by
156
References
41
FWCI
9.55
Type
journal article
Language
en
Open access
gold
Funders
Uniwersytet Medyczny w Białymstoku (SUB/1/DN/20/005/3301)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps. https://app.cochat.ai/papers/10.3390/nu12082401
The paper
Baczek, J., Silkiewicz, M., & Wojszel, Z. B. (2020). Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps. Nutrients. https://doi.org/10.3390/nu12082401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.